NCT ID | NCT01803282 |
Title | Safety and Tolerability Study in Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | yes |
Sponsors | Gilead Sciences |
Indications |
gastroesophageal junction adenocarcinoma |
Therapies | |
Age Groups: | adult |